Ampersand Ventures Invests in Signature Genomic Laboratories.SPOKANE, Wash. -- Ampersand The ampersand (&) normally means "and" as in Jones & Company. However, in the computer world, it is used in various ways. In Windows, it is used as a code to precede an underlined character. Ventures, a private equity firm focusing on investments in the health care and industrial technology sectors, has acquired a stake in Signature Genomic Laboratories, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control . In conjunction with the investment, Ampersand partners David J. Parker and Herbert H. Hooper, Ph.D. have been appointed to Signature's board of directors. They join current board members Lisa G. Shaffer, Ph.D., Signature's president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. ; Bassem A. Bejjani, M.D., Chief Medical Officer of Signature; and Ryland "Skip" Davis, Chief Executive of Providence Strategic Ventures, a division of Providence Health and Services. Ampersand joins Sacred Heart Medical Center Sacred Heart Medical Center may refer to: In the United States:
"We are very excited about Ampersand partnering with us because they will allow Signature to position itself favorably in this growing market," said Dr. Shaffer. "With both Ampersand's and Providence's experience in the clinical laboratory services industry, we are in an excellent position to identify new partners for strategic growth." Mr. Parker commented, "We are pleased to have the opportunity to support Signature's growth in the rapidly evolving market for microarray-based cytogenetic cytogenetic /cy·to·ge·net·ic/ (-je-net´ik) 1. pertaining to chromosomes. 2. pertaining to cytogenetics. cytogenetic pertaining to or originating from the origin and development of the cell. testing. Signature has established an attractive, growing business in this market through its strong clinical expertise, high-quality customer service and superior technology implementation. We look forward to working with Signature's management team to help take the company to the next level." About Signature Genomic Laboratories, LLC Signature Genomic Laboratories, founded in 2003 by Drs. Shaffer and Bejjani, provides state-of-the-art molecular cytogenetic diagnostic services. It was the first laboratory to provide microarray-based cytogenetic diagnostics with its proprietary SignatureChip([R]) and continues to be the leader in providing microarray-based chromosome analysis. Signature's worldwide client base includes clinical geneticists, neurologists, pediatricians, neonatologists, obstetricians, and the research community. Signature is CAP accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. , CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a certified, and licensed in the state of Washington. Additional information about Signature is available at www.signaturegenomics.com. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion